Adenosquamous carcinoma may have an inferior prognosis to signet ring cell carcinoma in patients with stages I and II gastric cancer

doi:10.4251/wjgo.v12.i1.101

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7253)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-4) series.

Item

Count

PDF

403

WORD

235

HTML

3705

Figures (1-3)

294

Tables (1-4)

349

Sum=4986

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

792

Download

1475

Sum=2267

Jan 15, 2020 (publication date) through Oct 2, 2024

Times Cited of This Article

Times Cited (4)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Jan 15, 2020; 12(1): 101-112
Published online Jan 15, 2020. doi: 10.4251/wjgo.v12.i1.101

Full Size Figure Download Figure

Figure 3 Kaplan-Meier plots of adenosquamous carcinoma vs signet ring cell carcinoma stratified by TNM stage. A: Stage I (P < 0.05); B: Stage II (P < 0.05); C: Stage III (P > 0.05); D: Stage IV (P > 0.05). ASC: Adenosquamous carcinoma; SRC: Signet ring cell carcinoma.

Citation: Chu YX, Gong HY, Hu QY, Song QB. Adenosquamous carcinoma may have an inferior prognosis to signet ring cell carcinoma in patients with stages I and II gastric cancer. World J Gastrointest Oncol 2020; 12(1): 101-112
URL: https://www.wjgnet.com/1948-5204/full/v12/i1/101.htm
DOI: https://dx.doi.org/10.4251/wjgo.v12.i1.101